查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877803

2025年全球体外诊断设备市场报告

In-Vitro Diagnostics Instruments Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，体外诊断设备市场成长显着，预计将从2024年的555.9亿美元成长到2025年的610.9亿美元，复合年增长率为9.9%。过去几年的成长主要受以下因素驱动：慢性病发病率上升、自动化检测系统应用日益广泛、预防医学意识提升、医院和诊所基础设施扩建以及政府对医疗保健项目的投入增加。

预计未来几年体外诊断市场规模将快速成长，到2029年将达到901.3亿美元，复合年增长率（CAGR）为10.2%。预测期内的成长将主要受以下因素驱动：个人化医疗需求的成长、快速诊断测试需求的成长、家庭诊断需求的成长以及人们对抗菌素抗药性的认识不断提高。预测期内的关键趋势包括：小型化诊断设备的开发、高通量平台的进步、与电子健康记录的整合、检查室机器人技术的应用以及生物感测器技术的创新。

慢性病和文明病的日益普遍预计将在未来几年推动体外诊断市场的成长。慢性病和文明病是指主要受日常习惯、行为和环境因素影响的长期健康状况（例如心臟病、糖尿病、肥胖症和某些癌症）。由于久坐不动的生活方式和不健康的饮食习惯，这些疾病的发生率正在上升。随着慢性病和文明病的日益普遍，各公司致力于推出早期检测和监测工具以改善疾病管理，这推动了对体外诊断的需求不断增长。例如，根据总部位于美国的非营利中间偏右智库「美国）称，截至2024年，慢性病已成为美国一项重大的公共卫生问题，约60%的成年人患有至少一种慢性病，40%的成年人患有多种慢性病，预计到2050年，这一患病率将几乎翻一番。此外，慢性病治疗市场预计将从2025年的97.4亿美元成长到2034年的约380.2亿美元。因此，慢性病和文明病的日益增加正在推动体外诊断设备市场的成长。

体外诊断市场的主要企业正致力于开发先进技术，例如数位聚合酵素链锁反应(dPCR) 系统，以实现高精度、高灵敏度的核酸定量，从而推动下一代诊断的发展。数位聚合酵素链锁反应(dPCR) 系统是一种先进的诊断设备，它透过将样本分成数千个独立的反应来定量 DNA 或 RNA 分子，从而实现卓越的检测准确性和灵敏度。例如，总部位于荷兰的生物技术公司 QIAGEN NV 于 2024 年 9 月推出了 QIAcuityDx 数位 PCR 系统，将其 dPCR 产品组合扩展到临床诊断领域，主要专注于肿瘤检测。这款完全整合、自动化的系统专为临床应用而设计，其基于试剂盒的工作流程最大限度地减少了人工操作。 QIAcuityDx 配备了自动化分析和报告软体，能够快速且准确地检测用于癌症诊断和治疗监测的遗传生物标记物，在确保结果可靠且可重复的同时，减少操作人员的参与。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外诊断设备市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 终端用户产业分析
  • 全球体外诊断设备市场：增长率分析
  • 全球体外诊断设备市场表现：规模与成长，2019-2024年
  • 全球体外诊断设备市场预测：规模与成长，2024-2029年，2034年预测
  • 全球体外诊断设备市场：潜在市场规模（TAM）

第六章 市场细分

  • 全球体外诊断设备市场：依产品类型、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 临床化学
  • 免疫检测
  • 分子诊断
  • 血液学
  • 微生物学
  • 凝血
  • 其他产品类型
  • 全球体外诊断设备市场：依应用、效能及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 感染疾病
  • 癌症
  • 心臟病学
  • 肾臟病学
  • 自体免疫疾病
  • 其他用途
  • 全球体外诊断设备市场：依最终用户划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 医院和诊断检查室
  • 学术研究机构
  • 照护现场环境
  • 血库
  • 製药和生物技术公司
  • 其他医疗机构
  • 全球体外诊断设备市场：依临床化学、类型、性能及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 自动临床化学分析仪
  • 半自动临床化学分析仪
  • 照护现场临床化学设备
  • 全球体外诊断设备市场：免疫检测、类型、性能及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 酵素免疫分析法（ELISA）系统
  • 化学冷光免疫检测分析 (CLIA) 分析仪
  • 免疫测量（RIA）系统
  • 全球体外诊断设备市场：依分子诊断、类型、性能及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 聚合酵素链锁反应（PCR）系统
  • 次世代定序（NGS）平台
  • 去氧核糖核酸微阵列
  • 等温放大装置
  • 全球体外诊断设备市场：依血液学、类型、性能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 自动血液分析仪
  • 手动血液分析仪
  • 止血分析仪
  • 凝血分析仪
  • 全球体外诊断设备市场：依微生物学、类型、性能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 微生物鑑定係统
  • 抗菌药物敏感性测试（AST）系统
  • 血液培养系统
  • 自动微生物分析仪。
  • 全球体外诊断设备市场：依凝血、类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 凝血测量装置
  • 血小板功能分析仪
  • 血栓弹力图（TEG）系统
  • 照护现场凝血测量装置
  • 全球体外诊断设备市场：依产品类型、类型、性能及预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 照护现场诊断设备
  • 临床化学试剂
  • 诊断影像设备
  • 其他检测设备

第七章 区域和国家分析

  • 全球体外诊断设备市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球体外诊断设备市场：依国家、绩效及预测划分，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 体外诊断设备市场：竞争格局
  • 体外诊断设备市场：公司概况
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Illumina Inc.
  • Hologic Inc.
  • Qiagen NV
  • Bio-Rad Laboratories Inc.
  • Agilent Technologies
  • Becton Dickinson and Company（BD）
  • Sysmex Corporation
  • Laboratory Corporation of America Holdings（LabCorp）
  • Guardant Health Inc.
  • Quest Diagnostics Inc.
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • Natera Inc.
  • NeoGenomics Laboratories Inc.
  • NanoString Technologies Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年体外诊断设备市场：提供新机会的国家
  • 2029年体外诊断设备市场：新兴细分市场机会
  • 2029年体外诊断设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39278

In-vitro diagnostic instruments are medical devices used to analyze biological samples, such as blood, urine, or tissue, outside the human body. Their primary function is to detect, diagnose, monitor, and manage diseases or medical conditions by providing accurate and timely laboratory test results. These instruments aid clinical decision-making and support personalized patient care.

The primary product types of in-vitro diagnostic instruments include clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, coagulation, and others. Clinical chemistry instruments are digital tools, often leveraging AI, to analyze blood, urine, and other body fluids, helping identify biochemical abnormalities, improve diagnostic accuracy, and guide treatment planning. These instruments are applied across multiple areas, including infectious diseases, cancer, cardiology, nephrology, and autoimmune disorders. They serve a diverse range of end users, including hospitals, diagnostic laboratories, academic and research institutes, point-of-care facilities, blood banks, and pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The in-vitro diagnostics instruments market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics instruments market statistics, including in-vitro diagnostics instruments industry global market size, regional shares, competitors with a in-vitro diagnostics instruments market share, detailed in-vitro diagnostics instruments market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics instruments industry. This in-vitro diagnostics instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro diagnostics instruments market size has grown strongly in recent years. It will grow from $55.59 billion in 2024 to $61.09 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period is driven by increasing prevalence of chronic diseases, growing adoption of automated laboratory systems, rising awareness of preventive healthcare, increasing hospital and clinic infrastructure, and growing government funding for healthcare initiatives.

The in-vitro diagnostics instruments market size is expected to see rapid growth in the next few years. It will grow to $90.13 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period is driven by the increasing demand for personalized medicine, growing demand for rapid diagnostic tests, rising demand for home-based diagnostics, and increasing awareness of antimicrobial resistance. Primary trends in the forecast period include the development of miniaturized diagnostic devices, advancement in high-throughput platforms, integration with electronic health records, incorporation of robotics in laboratories, and innovation in biosensor technologies.

The rising prevalence of chronic and lifestyle related diseases is expected to enhance the growth of the in vitro diagnostics instruments market in the coming years. Chronic and lifestyle related diseases refer to long term health conditions primarily influenced by daily habits, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The incidence of these diseases is increasing due to sedentary lifestyles and unhealthy dietary habits. In vitro diagnostics instruments are experiencing higher demand as the growing burden of chronic and lifestyle related diseases encourages companies to adopt early detection and monitoring tools for improved disease management. For example, in 2024, according to the American Action Forum, a U.S. based non profit, center right think tank, chronic diseases remain a major public health concern in the United States, with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Furthermore, the chronic disease treatment market is projected to reach approximately 38.02 billion dollars by 2034, up from 9.74 billion dollars in 2025. Therefore, the rising prevalence of chronic and lifestyle related diseases is enhancing the growth of the in vitro diagnostics instruments market.

Prominent companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced technologies, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for next-generation diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic instruments that quantify DNA or RNA molecules by dividing samples into thousands of individual reactions, allowing for exceptional accuracy and sensitivity in detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its dPCR portfolio into clinical diagnostics with a primary focus on oncology testing. This fully integrated and automated system is specifically designed for clinical use, featuring a cartridge-based workflow that minimizes manual handling. Equipped with automated analysis and reporting software, the QIAcuityDx enables rapid and precise detection of genetic biomarkers for cancer diagnosis and therapy monitoring, reducing operator involvement while ensuring reliable and reproducible results.

In January 2025, Fremman Ltd., a UK-based investment company, acquired a majority stake in DIESSE Diagnostica Senese S.p.A. for an undisclosed amount. Through this acquisition, Fremman Ltd aims to expand DIESSE Diagnostica Senese's international presence, strengthen its leadership in specialty in vitro diagnostics, and support ongoing innovation to advance global diagnostic capabilities and improve patient outcomes. DIESSE Diagnostica Senese S.p.A. is an Italy-based medical equipment company that provides in vitro diagnostic instruments.

Major players operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, Laboratory Corporation of America Holdings (LabCorp), Guardant Health Inc., Quest Diagnostics Inc., Exact Sciences Corporation, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., NanoString Technologies Inc., Veracyte Inc., Invitae Corporation, Foundation Medicine Inc. (Roche), Caris Life Sciences, Personalis Inc., OncoCyte Corporation, Freenome Holdings Inc., Epic Sciences Inc.

North America was the largest region in the in-vitro diagnostics instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro diagnostics instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in-vitro diagnostics instruments market consists of sales of point-of-care testing devices, flow cytometry instruments, histopathology and cytology instruments, and molecular point-of-care systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Diagnostics Instruments Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro diagnostics instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro diagnostics instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro diagnostics instruments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Clinical Chemistry; Immunoassay; Molecular Diagnostics; Hematology; Microbiology; Coagulation; Other Product Types
  • 2) By Application: Infectious Diseases; Cancer; Cardiology; Nephrology; Autoimmune Diseases; Other Applications
  • 3) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Point-Of-Care Settings; Blood Banks; Pharmaceutical And Biotechnology Companies; Other Healthcare Facilities
  • Subsegments:
  • 1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers; Semi-Automated Clinical Chemistry Analyzers; Point-Of-Care Clinical Chemistry Devices
  • 2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems; Chemiluminescence Immunoassay (CLIA) Analyzers; Radioimmunoassay (RIA) Systems
  • 3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Deoxyribonucleic Acid Microarrays; Isothermal Amplification Devices
  • 4) By Hematology: Automated Hematology Analyzers; Manual Hematology Analyzers; Hemostasis Analyzers; Coagulation Analyzers
  • 5) By Microbiology: Microbial Identification Systems; Antibiotic Susceptibility Testing (AST) Systems; Blood Culture Systems; Automated Microbial Analyzers.
  • 6) By Coagulation: Coagulometers; Platelet Function Analyzers; Thromboelastography (TEG) Systems; Point-Of-Care Coagulation Devices
  • 7) By Other Product Types: Point-Of-Care Diagnostic Devices; Clinical Chemistry Reagents; Diagnostic Imaging Instruments; Miscellaneous Laboratory Instruments
  • Companies Mentioned: F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Agilent Technologies, Becton, Dickinson and Company (BD), Sysmex Corporation, Laboratory Corporation of America Holdings (LabCorp), Guardant Health Inc., Quest Diagnostics Inc., Exact Sciences Corporation, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., NanoString Technologies Inc., Veracyte Inc., Invitae Corporation, Foundation Medicine Inc. (Roche), Caris Life Sciences, Personalis Inc., OncoCyte Corporation, Freenome Holdings Inc., Epic Sciences Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Diagnostics Instruments Market Characteristics

3. In-Vitro Diagnostics Instruments Market Trends And Strategies

4. In-Vitro Diagnostics Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In-Vitro Diagnostics Instruments Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-Vitro Diagnostics Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-Vitro Diagnostics Instruments Market Growth Rate Analysis
  • 5.4. Global In-Vitro Diagnostics Instruments Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-Vitro Diagnostics Instruments Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-Vitro Diagnostics Instruments Total Addressable Market (TAM)

6. In-Vitro Diagnostics Instruments Market Segmentation

  • 6.1. Global In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Chemistry
  • Immunoassay
  • Molecular Diagnostics
  • Hematology
  • Microbiology
  • Coagulation
  • Other Product Types
  • 6.2. Global In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Other Applications
  • 6.3. Global In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Diagnostic Laboratories
  • Academic And Research Institutes
  • Point-Of-Care Settings
  • Blood Banks
  • Pharmaceutical And Biotechnology Companies
  • Other Healthcare Facilities
  • 6.4. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Clinical Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Clinical Chemistry Analyzers
  • Semi-Automated Clinical Chemistry Analyzers
  • Point-Of-Care Clinical Chemistry Devices
  • 6.5. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA) Systems
  • Chemiluminescence Immunoassay (CLIA) Analyzers
  • Radioimmunoassay (RIA) Systems
  • 6.6. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR) Systems
  • Next-Generation Sequencing (NGS) Platforms
  • Deoxyribonucleic Acid Microarrays
  • Isothermal Amplification Devices
  • 6.7. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Hematology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Hematology Analyzers
  • Manual Hematology Analyzers
  • Hemostasis Analyzers
  • Coagulation Analyzers
  • 6.8. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Microbiology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbial Identification Systems
  • Antibiotic Susceptibility Testing (AST) Systems
  • Blood Culture Systems
  • Automated Microbial Analyzers.
  • 6.9. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Coagulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coagulometers
  • Platelet Function Analyzers
  • Thromboelastography (TEG) Systems
  • Point-Of-Care Coagulation Devices
  • 6.10. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Point-Of-Care Diagnostic Devices
  • Clinical Chemistry Reagents
  • Diagnostic Imaging Instruments
  • Miscellaneous Laboratory Instruments

7. In-Vitro Diagnostics Instruments Market Regional And Country Analysis

  • 7.1. Global In-Vitro Diagnostics Instruments Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-Vitro Diagnostics Instruments Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Diagnostics Instruments Market

  • 8.1. Asia-Pacific In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Diagnostics Instruments Market

  • 9.1. China In-Vitro Diagnostics Instruments Market Overview
  • 9.2. China In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Diagnostics Instruments Market

  • 10.1. India In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Diagnostics Instruments Market

  • 11.1. Japan In-Vitro Diagnostics Instruments Market Overview
  • 11.2. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Diagnostics Instruments Market

  • 12.1. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Diagnostics Instruments Market

  • 13.1. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Diagnostics Instruments Market

  • 14.1. South Korea In-Vitro Diagnostics Instruments Market Overview
  • 14.2. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Diagnostics Instruments Market

  • 15.1. Western Europe In-Vitro Diagnostics Instruments Market Overview
  • 15.2. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Diagnostics Instruments Market

  • 16.1. UK In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Diagnostics Instruments Market

  • 17.1. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Diagnostics Instruments Market

  • 18.1. France In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Diagnostics Instruments Market

  • 19.1. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Diagnostics Instruments Market

  • 20.1. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Diagnostics Instruments Market

  • 21.1. Eastern Europe In-Vitro Diagnostics Instruments Market Overview
  • 21.2. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Diagnostics Instruments Market

  • 22.1. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Diagnostics Instruments Market

  • 23.1. North America In-Vitro Diagnostics Instruments Market Overview
  • 23.2. North America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Diagnostics Instruments Market

  • 24.1. USA In-Vitro Diagnostics Instruments Market Overview
  • 24.2. USA In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Diagnostics Instruments Market

  • 25.1. Canada In-Vitro Diagnostics Instruments Market Overview
  • 25.2. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Diagnostics Instruments Market

  • 26.1. South America In-Vitro Diagnostics Instruments Market Overview
  • 26.2. South America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Diagnostics Instruments Market

  • 27.1. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Diagnostics Instruments Market

  • 28.1. Middle East In-Vitro Diagnostics Instruments Market Overview
  • 28.2. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Diagnostics Instruments Market

  • 29.1. Africa In-Vitro Diagnostics Instruments Market Overview
  • 29.2. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Diagnostics Instruments Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Diagnostics Instruments Market Competitive Landscape
  • 30.2. In-Vitro Diagnostics Instruments Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Diagnostics Instruments Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Hologic Inc.
  • 31.3. Qiagen N.V.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Agilent Technologies
  • 31.6. Becton Dickinson and Company (BD)
  • 31.7. Sysmex Corporation
  • 31.8. Laboratory Corporation of America Holdings (LabCorp)
  • 31.9. Guardant Health Inc.
  • 31.10. Quest Diagnostics Inc.
  • 31.11. Exact Sciences Corporation
  • 31.12. Myriad Genetics Inc.
  • 31.13. Natera Inc.
  • 31.14. NeoGenomics Laboratories Inc.
  • 31.15. NanoString Technologies Inc.

32. Global In-Vitro Diagnostics Instruments Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Diagnostics Instruments Market

34. Recent Developments In The In-Vitro Diagnostics Instruments Market

35. In-Vitro Diagnostics Instruments Market High Potential Countries, Segments and Strategies

  • 35.1 In-Vitro Diagnostics Instruments Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Diagnostics Instruments Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Diagnostics Instruments Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer